Business Elon Musk’s neurotechnology unicorn may have misled the SEC: Here’s how that could get ugly Published 3 years ago on 4 February 2022 By Terry Power Elon Musk’s neurotechnology unicorn may have misled the SEC: Here’s how that could get ugly | Fortune You need to enable JavaScript to view this site. Related Topics:Elonelon muskHeresIPOsmisledMusksNeuralinkneurotechnologyprivate equityprivate equity dealsprivate equity exitsprivate equity firmsprivate equity fundingprivate equity fundsSECStartupstech startupsTerm SheetteslauglyunicornvcVC dealsVC firmsVC fundingVC fundsVC investorsventure capitalventure capital dealsventure capital exitsventure capital firmsventure capital fundingventure capital fundsventure capital investorsventure dealsventure firmsventure fundingventure fundsventure investors